Skip to main content

CDC Anthrax Vaccine Safety & Efficacy Research Program Interim Report (2001) / Chapter Skim
Currently Skimming:

Appendix A: Study Activities
Pages 41-42

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 41...
... The entire project leading to production of a full report reviewing the CDC's anthrax vaccine research program was planned for 24 months, to be completed contingent upon funding for the second year. The committee included members with expertise in infectious disease epidemiology; vaccinology; drug/vaccine research, development, testing, and evaluation; post-marketing surveillance of adverse events, inclucling the Vaccine Aclverse Events Reporting System (VAERS)
Read the entire page →

Key Terms

  • anthrax vaccine
  • events reporting
  • vaccine research
  • address risk
  • closes required

  • including gentler
  • committee included
  • vaccination schedule
  • infectious disease
  • aclverse events

  • project leading
  • assure efficacy
  • health surveillance
  • entire project
  • disease epidemiology

  • gender differences
  • gentler differences
  • licensing procedures
  • vaccine efficacy
  • report reviewing

  • risk factors
  • vaccine aclverse
  • adverse reactions
  • immunologic correlates
  • completed contingent

  • research program
  • related committee
  • interim report
  • advisory committee
  • committee met


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.